ALL MARKETS
FTSE 100
FTSE 250
AIM MARKET


OKYO Pharma Corp.
104 announcements.
Time Date Ticker Company Announcement
07:00 09-09-2021 OKYO OKYO Pharma Limited
Notice of AGM
07:00 09-09-2021 OKYO OKYO Pharma LTD
OKYO Pharma Limited ("OKYO" or the "Company") - Notice of Annual General Meeting
07:00 01-09-2021 OKYO OKYO Pharma Limited
Director/PDMR Shareholding
11:57 02-08-2021 OKYO OKYO Pharma LTD
OKYO Pharma Limited Announces final audited results for the year ended 31 March 2021
11:32 02-08-2021 OKYO OKYO Pharma Limited
Annual Financial Report
13:14 29-06-2021 OKYO OKYO Pharma LTD
("OKYO" or the "Company") - OKYO Pharma Retains Ora Inc. to Perform Regulatory Development of OK-101 for Dry Eye Indications
07:00 29-06-2021 OKYO OKYO Pharma Limited
Research Update
15:58 17-06-2021 OKYO OKYO Pharma Limited
Directorate Change
07:00 12-05-2021 OKYO OKYO Pharma Limited
Holding(s) in Company
10:07 07-05-2021 OKYO OKYO Pharma Limited
Additional Listing
11:53 05-05-2021 OKYO OKYO Pharma Limited
Publication of a Prospectus
07:00 28-04-2021 OKYO OKYO Pharma Limited
Positive Data in an Animal Model using OK-201
07:00 29-03-2021 OKYO OKYO Pharma Limited
Appointment of Chief Scientific Officer
07:00 03-03-2021 OKYO OKYO Pharma Limited
Issue of Equity
07:00 01-03-2021 OKYO OKYO Pharma Limited
Issue of Equity
07:00 23-02-2021 OKYO OKYO Pharma Limited
Patent for treating Ocular Pain and Inflammation
07:00 19-01-2021 OKYO OKYO Pharma Limited
Filing patent application for the use of Chemerin
16:41 14-01-2021 OKYO OKYO Pharma Limited
Second Price Monitoring Extn
16:37 14-01-2021 OKYO OKYO Pharma Limited
Price Monitoring Extension
14:05 14-01-2021 OKYO OKYO Pharma Limited
Second Price Monitoring Extn
14:00 14-01-2021 OKYO OKYO Pharma Limited
Price Monitoring Extension
07:00 07-01-2021 OKYO OKYO Pharma Limited
Directorate Change
07:00 30-11-2020 OKYO OKYO Pharma Limited
Half-year Report
16:40 14-10-2020 OKYO OKYO Pharma Limited
Second Price Monitoring Extn
16:36 14-10-2020 OKYO OKYO Pharma Limited
Price Monitoring Extension
14:05 14-10-2020 OKYO OKYO Pharma Limited
Second Price Monitoring Extn
14:00 14-10-2020 OKYO OKYO Pharma Limited
Price Monitoring Extension
16:41 13-10-2020 OKYO OKYO Pharma Limited
Second Price Monitoring Extn
16:36 13-10-2020 OKYO OKYO Pharma Limited
Price Monitoring Extension
14:05 13-10-2020 OKYO OKYO Pharma Limited
Second Price Monitoring Extn
14:00 13-10-2020 OKYO OKYO Pharma Limited
Price Monitoring Extension
11:05 13-10-2020 OKYO OKYO Pharma Limited
Second Price Monitoring Extn
11:00 13-10-2020 OKYO OKYO Pharma Limited
Price Monitoring Extension
14:05 09-10-2020 OKYO OKYO Pharma Limited
Second Price Monitoring Extn
14:00 09-10-2020 OKYO OKYO Pharma Limited
Price Monitoring Extension
11:05 09-10-2020 OKYO OKYO Pharma Limited
Second Price Monitoring Extn
11:00 09-10-2020 OKYO OKYO Pharma Limited
Price Monitoring Extension
09:05 09-10-2020 OKYO OKYO Pharma Limited
Second Price Monitoring Extn
09:00 09-10-2020 OKYO OKYO Pharma Limited
Price Monitoring Extension
16:40 25-09-2020 OKYO OKYO Pharma Limited
Second Price Monitoring Extn
16:35 25-09-2020 OKYO OKYO Pharma Limited
Price Monitoring Extension
12:00 25-09-2020 OKYO OKYO Pharma LTD
OKYO Pharma Limited ("OKYO" or the "Company") - Result of the Annual General Meeting
12:00 25-09-2020 OKYO OKYO Pharma Limited
Notice of Results: AGM
12:00 25-09-2020 OKYO OKYO Pharma Limited
Upload of Articles of Association to NSM
07:00 09-09-2020 OKYO OKYO Pharma LTD
Notice of Annual General Meeting
07:00 09-09-2020 OKYO OKYO Pharma Limited
Notice of AGM
09:17 08-09-2020 OKYO OKYO Pharma Limited
Issue of convertible loan notes
07:00 21-08-2020 OKYO OKYO Pharma Limited
Grant of options - Director dealings
07:00 19-08-2020 OKYO OKYO Pharma LTD
OKYO Pharma Limited ("OKYO" or the "Company") - Appointment of Dr. Napoleone Ferrara to Serve on Its Scientific Advisory Board
07:00 19-08-2020 OKYO OKYO Pharma Limited
Dr. Napoleone Ferrara to Serve on the SAB
14:06 18-08-2020 OKYO OKYO Pharma Limited
Second Price Monitoring Extn
14:01 18-08-2020 OKYO OKYO Pharma Limited
Price Monitoring Extension
07:00 18-08-2020 OKYO OKYO Pharma Limited
OKYO: CLNs to raise £1.4m, intends to list: NASDAQ
07:00 18-08-2020 OKYO OKYO Pharma LTD
OKYO Pharma Limited ("OKYO" or the "Company") - Issue of additional convertible loan notes to raise £1,437,104 and intention to seek dual listing on NASDAQ
17:00 17-08-2020 OKYO OKYO Pharma Limited
Final audited results for year ended 31 March 2020
16:41 17-08-2020 OKYO OKYO Pharma Limited
Second Price Monitoring Extn
16:35 17-08-2020 OKYO OKYO Pharma Limited
Price Monitoring Extension
07:00 07-08-2020 OKYO OKYO Pharma Limited
Dr James Khodabakhsh MD named Chairman of the SAB
07:00 07-08-2020 OKYO OKYO Pharma LTD
Dr James Khodabakhsh MD named Chairman of the Scientific Advisory Board at OKYO Pharma Ltd
07:00 06-08-2020 OKYO OKYO Pharma Limited
Holding(s) in Company
16:40 03-08-2020 OKYO OKYO Pharma Limited
Second Price Monitoring Extn
16:35 03-08-2020 OKYO OKYO Pharma Limited
Price Monitoring Extension
14:05 03-08-2020 OKYO OKYO Pharma Limited
Second Price Monitoring Extn
14:00 03-08-2020 OKYO OKYO Pharma Limited
Price Monitoring Extension
11:05 03-08-2020 OKYO OKYO Pharma Limited
Second Price Monitoring Extn
11:00 03-08-2020 OKYO OKYO Pharma Limited
Price Monitoring Extension
09:05 03-08-2020 OKYO OKYO Pharma Limited
Second Price Monitoring Extn
09:00 03-08-2020 OKYO OKYO Pharma Limited
Price Monitoring Extension
07:00 03-08-2020 OKYO OKYO Pharma LTD
OKYO Pharma Limited ("OKYO" or the "Company") - Company Presentation
16:30 31-07-2020 OKYO OKYO Pharma LTD
OKYO Pharma Limited - Upcoming Presentation
11:14 28-07-2020 OKYO OKYO Pharma LTD
OKYO Pharma Limited ("OKYO" or the "Company") - Issue of convertible loan notes to raise £3,500,000
08:51 28-07-2020 OKYO OKYO Pharma Limited
Issue of convertible loan notes
16:42 10-06-2020 OKYO OKYO Pharma Limited
Directorate Change
10:32 05-06-2020 OKYO OKYO Pharma Limited
Notification of Major Holdings
11:09 03-06-2020 OKYO OKYO Pharma Limited
Appointment of Broker
14:13 27-05-2020 OKYO OKYO Pharma Limited
Holding(s) in Company
10:45 27-04-2020 OKYO OKYO Pharma Limited
Holding(s) in Company
07:00 30-03-2020 OKYO OKYO Pharma Limited
Holding(s) in Company
07:00 23-03-2020 OKYO OKYO Pharma Limited
Update on Placing to raise £560,000
07:00 19-03-2020 OKYO OKYO Pharma Limited
Placing to raise £560,000
11:50 02-03-2020 OKYO OKYO Pharma Limited
Result of AGM
07:00 19-12-2019 OKYO OKYO Pharma Limited
Directorate Change
07:00 29-11-2019 OKYO OKYO Pharma Limited
Half-year Report
07:00 28-08-2019 OKYO OKYO Pharma Limited
Chemerin Update
07:00 19-08-2019 OKYO OKYO Pharma Limited
Collaboration with Prof. Pedram Hamrah
14:05 30-07-2019 OKYO OKYO Pharma Limited
Second Price Monitoring Extn
14:00 30-07-2019 OKYO OKYO Pharma Limited
Price Monitoring Extension
07:00 01-07-2019 OKYO OKYO Pharma Limited
Final Results
14:52 30-05-2019 OKYO OKYO Pharma Limited
Holding(s) in Company
10:58 20-05-2019 OKYO OKYO Pharma Limited
Result of General Meeting
07:00 26-04-2019 OKYO OKYO Pharma Limited
Subscription and Waiver
17:30 25-04-2019 OKYO OKYO Pharma Limited
Holding(s) in Company
07:00 07-03-2019 OKYO OKYO Pharma Limited
Presentation of Preclinical Data
07:00 23-01-2019 OKYO OKYO Pharma Limited
Corporate Update
16:06 30-11-2018 OKYO OKYO Pharma Limited
Half-year Report
07:00 01-11-2018 OKYO OKYO Pharma Limited
Expected Admission Date for Consideration Shares
07:00 24-10-2018 OKYO OKYO Pharma Limited
Allotment of Ordinary Shares & Listing Application
07:00 21-09-2018 OKYO OKYO Pharma Limited
Appointment of Senior R&D Director
12:38 06-09-2018 OKYO OKYO Pharma Limited
Result of AGM
12:13 22-08-2018 OKYO OKYO Pharma Limited
Holding(s) in Company
12:09 21-08-2018 OKYO OKYO Pharma Limited
Annual Report and Notice of AGM
17:00 21-02-2018 OKYO OKYO Pharma Corp
Proposed cancellation, suspension, notice of GM
12:47 02-03-2018 OKYO OKYO Pharma Corp
Change of Broker
11:01 09-03-2018 OKYO OKYO Pharma Corp
Result of General Meeting and Corporate Update